1 active not recruiting, 1 completed, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Indena S.p.A: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain 3-glycosyl-3-Odemethylthiocolchicine derivative - Low Back Pain | Phase 2 | Withdrawn | Indena S.p.A | 2016-04-01 | 2025-07-22 | |
| Safety of Ginkgo Biloba Leaf Extract Gingko Biloba Extract, Placebo - Healthy | Phase 2 | Unknown | IRCCS San Raffaele | 66 | 2015-07-01 | 2016-12-30 |
| Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients SAMITAL®, Placebo sachets - Head-and-neck Squamous Cell Carcinoma, Oral Mucositis | Phase 2 | Completed | Istituto Oncologico Veneto IRCCS | 120 | 2012-12-01 | 2018-09-13 |
| The Effects of Ginseng on Cancer-Related Fatigue Panax Ginseng, Placebo, Questionnaires - Advanced Cancers, Solid Tumors | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 165 | 2011-10-14 | 2026-10-08 |
Carcinoma, Squamous Cell (1) · Genomic Instability (1) · Low Back Pain (1) · Muscle Hypotonia (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomatitis (1)
Asian ginseng (1) · Ginkgo Extract (1) · Sugars (1) · Surveys and Questionnaires (1) · samital (1)
Italy (3) · United States (1)
Gianfranco Ferraccioli, MD (1) · Lucio Loreggian, MD (1) · Sriram Yennurajalingam, MD (1) · Stefano Bonassi, PhD (1)
PMID 12213959, PMID 16973674, PMID 23410167, PMID 23652021, PMID 24184488, PMID 25446328, PMID 28874596, PMID 29357859, PMID 36551677